Int Urogynecol J (2017) 28:1335–1340 DOI 10.1007/s00192-017-3266-y ORIGINAL ARTICLE Which bladder instillations are more effective? DMSO vs. bupivacaine/heparin/triamcinolone: a retrospective study 1 1 1 1 1 Shilpa Iyer & Elizabeth Lotsof & Ying Zhou & Alexis Tran & Carolyn Botros & 1 1 1 1 1 Peter Sand & Roger Goldberg & Janet Tomezsko & Adam Gafni-Kane & Sylvia Botros Received: 16 August 2016 /Accepted: 3 January 2017 /Published online: 1 February 2017 The International Urogynecological Association 2017 Abstract Compared with baseline, DMSO patients reported 63% im- Introduction and hypothesis Bladder pain syndrome/ provement (p < 0.0001), increased time between daytime interstitial cystitis (BPS/IC) is a chronic and debilitating con- voids by 1.5 h (p < 0.00), and a 40% reduction in nocturia dition. Our objective was to compare two different bladder episodes (p < 0.00). B/H/T patients reported 51% improve- instillation treatments in patients with BPS/IC: dimethyl sulf- ment (p < 0.00), increased time between daytime voids by oxide with triamcinolone (DMSO) vs. bupivacaine with hep- 1.4 h (p < 0.00), and an 8% reduction in nocturia episodes arin and triamcinolone (B/H/T). Our hypothesis was that both (p = 0.26). When comparing the two treatments, DMSO re- treatments
International Urogynecology Journal – Springer Journals
Published: Feb 1, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud